Barrington Research Brokers Lift Earnings Estimates for OPCH

Option Care Health, Inc. (NASDAQ:OPCH - Free Report) - Equities researchers at Barrington Research increased their FY2025 EPS estimates for Option Care Health in a note issued to investors on Wednesday, April 30th. Barrington Research analyst M. Petusky now expects that the company will post earnings of $1.50 per share for the year, up from their prior forecast of $1.47. Barrington Research has a "Outperform" rating and a $38.00 price objective on the stock. The consensus estimate for Option Care Health's current full-year earnings is $1.22 per share. Barrington Research also issued estimates for Option Care Health's Q1 2026 earnings at $0.36 EPS, Q2 2026 earnings at $0.41 EPS and Q3 2026 earnings at $0.43 EPS.

Option Care Health (NASDAQ:OPCH - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same quarter in the previous year, the firm posted $0.26 EPS. The firm's quarterly revenue was up 16.3% on a year-over-year basis.

Several other equities analysts have also recently issued reports on OPCH. Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. JPMorgan Chase & Co. upped their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and increased their price objective for the company from $26.00 to $33.00 in a report on Monday, January 13th. JMP Securities reissued a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Option Care Health presently has a consensus rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Stock Up 0.8 %

Shares of Option Care Health stock traded up $0.27 during trading on Friday, reaching $33.01. The company had a trading volume of 512,330 shares, compared to its average volume of 1,826,007. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market cap of $5.40 billion, a price-to-earnings ratio of 27.71, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. Option Care Health has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The firm's fifty day moving average is $33.33 and its 200-day moving average is $28.85.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company's stock, valued at $1,495,835.24. The trade was a 40.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.64% of the stock is owned by company insiders.

Hedge Funds Weigh In On Option Care Health

A number of institutional investors and hedge funds have recently bought and sold shares of OPCH. Murphy & Mullick Capital Management Corp bought a new position in Option Care Health during the fourth quarter valued at about $26,000. UMB Bank n.a. boosted its stake in shares of Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after purchasing an additional 346 shares in the last quarter. Signaturefd LLC increased its holdings in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC grew its holdings in shares of Option Care Health by 172.8% during the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares during the last quarter. Finally, Public Employees Retirement System of Ohio raised its holdings in shares of Option Care Health by 21.6% in the fourth quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.